Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA launches new priority review voucher program for select biopharmas
mergers and acquisitions
Biotech
Taxes, tariffs, interest rates hold key to biotech's future: EY
“This is probably one of the toughest years to predict,” Arda Ural, Ph.D., EY Americas Life Sciences Sector Leader, said on last week.
Kevin Dunleavy
Jun 18, 2025 9:50am
China's rapid rise creates 'heightened risks' for pharma: PwC
Jun 18, 2025 5:00am
Eli Lilly pays $1B upfront to buy gene editing partner Verve
Jun 17, 2025 4:35am
Wojcicki prevails in 23andMe auction, with final $305M bid
Jun 16, 2025 10:40am
Medtronic adopts familiar name for its diabetes spinout: MiniMed
Jun 12, 2025 10:30am
BioNTech buys German mRNA vaccine peer CureVac in $1.2B deal
Jun 12, 2025 8:17am
